Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:29 PM
Ignite Modification Date:
2025-12-24 @ 2:29 PM
NCT ID:
NCT05545059
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of resistant hypertension
* ≥18 and ≤75 years old at the time of randomization
* Must agree to comply with all requirements and sign the informed consent form
Exclusion Criteria:
* unwilling to sign informed consent.
* Severe renal insufficiency
* Research related drug contraindications
* secondary hypertension
* Cardiovascular event
* Persistent arrhythmia, valvular heart disease, and class III-IV heart failure or left ventricular ejection fraction \<45%.
* Severe liver function impairment (Child-Pugh C), biliary cirrhosis and/or cholestasis
* History of angioedema and asthma
* Woman of childbearing age who do not take effective contraceptive measures or pregnant or breastfeeding
* Allergic to drugs related to the study
* Suffering from serious tumor-related diseases, receives tumor-related treatment, or has a life expectancy of less than 2 years
* Planning to join other clinical trials
* Anticipated changes in medical conditions
* Need to take study-related drugs for reasons other than hypertension
* Suffering from other diseases that may prevent the patient from participating fully period of the study
* Other any concomitant conditions
* Must continuously take any drugs that affect the results
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05545059
Study Brief:
Protocol Section:
NCT05545059